Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-02-05 Sale |
2024-02-07 8:32 pm |
4D Molecular Therapeutics Inc. | FDMT | Kim Robert Young Chief Medical Officer |
24,552 | $30.05 | $737,788 | 257,043 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-06 Option Award |
2025-03-10 7:58 pm |
N/A 2035-03-05 |
4D Molecular Therapeutics Inc. | FDMT | Kim Robert Young Chief Medical Officer |
92,300 | $0 | 92,300 (Direct) |
View |
| 2024-02-05 Exercise |
2024-02-07 8:32 pm |
N/A N/A |
4D Molecular Therapeutics Inc. | FDMT | Kim Robert Young Chief Medical Officer |
6,000 | $8.04 | 257,043 (Direct) |
View |
| 2024-02-05 Exercise |
2024-02-07 8:32 pm |
N/A N/A |
4D Molecular Therapeutics Inc. | FDMT | Kim Robert Young Chief Medical Officer |
12,000 | $18.66 | 257,043 (Direct) |
View |
| 2024-02-05 Exercise |
2024-02-07 8:32 pm |
N/A N/A |
4D Molecular Therapeutics Inc. | FDMT | Kim Robert Young Chief Medical Officer |
6,000 | $15.78 | 257,043 (Direct) |
View |
| 2024-02-05 Exercise |
2024-02-07 8:32 pm |
N/A 2030-11-08 |
4D Molecular Therapeutics Inc. | FDMT | Kim Robert Young Chief Medical Officer |
24,000 | $0 | 257,043 (Direct) |
View |
Ownership(A) |
2024-02-07 7:42 pm |
N/A N/A |
4D Molecular Therapeutics Inc. | FDMT | Kim Robert Young Chief Medical Officer |
0 | $0 | 1,595 (Direct) |
View |
| 2023-12-11 Option Award |
2023-12-13 4:05 pm |
N/A 2033-12-10 |
4D Molecular Therapeutics Inc. | FDMT | Kim Robert Young Chief Medical Officer |
250,000 | $0 | 250,000 (Direct) |
View |
Ownership |
2023-04-05 9:28 pm |
N/A 2030-11-08 |
4D Molecular Therapeutics Inc. | FDMT | Kim Robert Young Chief Medical Officer |
0 | $0 | 320,000 (Direct) |
View |